Bloodstream infections with metallo-β-lactamase-producing Pseudomonas aeruginosa: Epidemiology, microbiology, and clinical outcomes

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 1, 2006, Pages 388-390

  Marra, Alexandre R ^a   Pereira, Carlos Alberto P ^a   Gales, Ana Cristina ^a   Menezes, Liana C ^a   Cal, Ruy Guilherme R ^b   De Souza, José Marconi A ^b   Edmond, Michael B ^c   Faro, Cynthia ^a   Wey, Sérgio B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; COLISTIN; IMIPENEM; METALLO BETA LACTAMASE; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; BACTERIUM ISOLATE; BLOOD CULTURE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPTICEMIA;

BACTEREMIA; BETA-LACTAMASES; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TREATMENT OUTCOME;

EID: 29944435930     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.1.388-390.2006     Document Type: Article

References (18)

1. Arakawa, Y., N. Shibata, K. Shibayama, H. Kurokawa, T. Yagi, H. Fujiwara, and M. Goto. 2000. Convenient test for screening metallo-β-lactamase- producing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol. 38:40-43.
2. Bush, K. 2001. New β-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin. Infect. Dis. 32:1085-1089.
3. GIM-1, encoding a new subclass of metallo-β-lactamase. Antimicrob. Agents Chemother. 48:4654-4661.
4. Crespo, M. P., N. Woodford, A. Sinclair, M. E. Kaufmann, J. Turton, J. Glover, J. D. Velez, C. R. Castaneda, M. Recalde, and D. M. Livermore. 2004. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-β-lactamase, in a tertiary care center in Cali, Colombia. J. Clin. Microbiol. 42:5094-5101.
5. Gales, A. C., L. C. Menezes, S. Silbert, and H. S. Sader. 2003. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase. J. Antimicrob. Chemother. 52:699-702.
6. Gales, A. C., A. O. Reis, and R. N. Jones. 2001. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J. Clin. Microbiol. 39:189-190.
7. Garner, J. S., W. R. Jarvis, T. B. Emori, T. C. Horan, and J. M. Hughes. 1988. CDC definitions for nosocomial infections. Am. J. Infect. Control. 16:128-140.
8. Hirakata, Y., T. Yamaguchi, M. Nakano, K. Izumikawa, M. Mine, S. Aoki, A. Kondoh, J. Matsuda, M. Hirayama, K. Yanagihara, Y. Miyazaki, K. Tomono, Y. Yamada, S. Kamihira, and S. Kohno. 2003. Clinical and bacteriological characteristics of IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa. Clin. Infect. Dis. 37:26-32.
9. Le Gall, J. R., S. Lemeshow, and F. Saulnier. 1993. A new simplified acute physiology score (SAPS II) based on an European/North American multicenter study. JAMA 270:2957-2963.
10. Livermore, D. M. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34:634-640.
11. Livermore, D. M., T. G. Winstanley, and K. P. Shannon. 2001. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J. Antimicrob. Chemother. 48(Suppl. 1):S87-S102.
12. IMP-16, and a fused form of aminoglycoside-resistant gene aac(6′)-30/aac(6′)-Ib′: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 48:4693-4702.
13. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing; eight informational supple-ment M100-S13. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Osano, E., Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura, and N. Kato. 1994. Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78.
15. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J. D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase, and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.
16. Sader, H. S., A. O. Reis, S. Silbert, and A. C. Gales. 2005. IMPs, VIMs and SPMs: the diversity of metallo-β-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital. Clin. Microbiol. Infect. 11:73-76.
17. Seifert, H., A. Strate, A. Schulze, and G. Pulverer. 1994. Bacteremia due to Acinetobacter species other than Acinetobacter baumannii. Infection 22:379-383.
18. Senda, K., Y. Arakawa, K. Nakashima, H. Ito, S. Ichiyama, K. Shimokata, N. Kato, and M. Ohta. 1996. Multifocal outbreaks of metallo-β-lactamase- producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob. Agents Chemother. 40:349-353.